Brown, Lisle/Cummings, Inc. Sanofi Transaction History
Brown, Lisle/Cummings, Inc.
- $345 Billion
- Q1 2025
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Sanofi stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 24 shares of SNY stock, worth $1,255. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24Holding current value
$1,255% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SNY
# of Institutions
829Shares Held
262MCall Options Held
1.82MPut Options Held
1.64M-
Dodge & Cox San Francisco, CA75.2MShares$3.94 Billion2.27% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.5MShares$655 Million0.24% of portfolio
-
Invesco Ltd. Atlanta, GA12.1MShares$631 Million0.11% of portfolio
-
Bank Of America Corp Charlotte, NC12MShares$629 Million0.05% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$567 Million0.06% of portfolio
About Sanofi
- Ticker SNY
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,508,100,096
- Market Cap $131B
- Description
- Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...